Musacci G F, Ansani L, Toselli T, Aggio S, Baracca E, Longhini C
Arzneimittelforschung. 1986 Feb;36(2A):380-2.
Peripheral hemodynamics were studied using strain gauge plethysmography in patients with congestive heart failure after administration of ibopamine (SB-7505), the orally active 3,4-diisobutyryl ester of N-methyldopamine, a dopaminergic agonist, and of sulpiride, a specific dopaminergic antagonist. 50 mg of sulpiride were administered parenterally in 12 patients 3 h after a single oral dose of 150 mg of ibopamine. Ibopamine increased significantly resting arterial blood flow and venous capacity and decreased peripheral resistance. Sulpiride was found to significantly counteract the activity of ibopamine.
在充血性心力衰竭患者中,使用应变计体积描记法研究外周血流动力学。这些患者服用了异波帕明(SB - 7505),它是N - 甲基多巴胺的口服活性3,4 - 二异丁酰酯,一种多巴胺能激动剂,还服用了舒必利,一种特异性多巴胺能拮抗剂。在单次口服150 mg异波帕明3小时后,对12例患者胃肠外给予50 mg舒必利。异波帕明显著增加静息动脉血流量和静脉容量,并降低外周阻力。发现舒必利能显著对抗异波帕明的活性。